CareCloud Inc (CCLD) concluded trading on Thursday at a closing price of $1.60, with 30.39 million shares of worth about $48.62 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -35.74% during that period and on March 13, 2025 the price remained unchanged. Currently the company’s common shares owned by public are about 16.22M shares, out of which, 8.29M shares are available for trading.
Stock saw a price change of -24.17% in past 5 days and over the past one month there was a price change of -64.44%. Year-to-date (YTD), CCLD shares are showing a performance of -56.28% which increased to 23.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.01 but also hit the highest price of $4.84 during that period. The average intraday trading volume for CareCloud Inc shares is 185.77K. The stock is currently trading -45.97% below its 20-day simple moving average (SMA20), while that difference is down -51.73% for SMA50 and it goes to -43.10% lower than SMA200.
CareCloud Inc (NASDAQ: CCLD) currently have 16.22M outstanding shares and institutions hold larger chunk of about 9.85% of that.
The stock has a current market capitalization of $26.01M and its 3Y-monthly beta is at 1.98. It has posted earnings per share of -$3.19 in the same period. It has Quick Ratio of 1.01 while making debt-to-equity ratio of 0.08. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCLD, volatility over the week remained 27.98% while standing at 14.65% over the month.
Analysts are in expectations that CareCloud Inc (CCLD) stock would likely to be making an EPS of 0.09 in the current quarter, while forecast for next quarter EPS is 0.08 and it is 0.64 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.07 which is 0.1 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 0.01 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 112.50% while it is estimated to increase by 414.29% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by ROTH MKM on November 13, 2024 offering a Neutral rating for the stock and assigned a target price range of between $5 and $3.50 to it.
